Breaking News

TOT Biopharm Opens Suzhou Production Facility

December 3, 2012

Completes first stage of construction

TOT Biopharm Co. Ltd. has completed the first stage of construction of its $100 million factory complex in eastern China's Suzhou Industrial Park. The 50,000-sq.-m. facility complex specializes in the R&D, production and marketing of anti-cancer drugs globally. The company's core products include liposomal technology-based specialty drugs, biologics and innovative drugs.
The first stage of the new factory complex includes an oral anti-cancer drug plant with separate production facilities for cytotoxics and non-cytotoxics, an injected anti-cancer drug plant, and a GMP pilot plant with 500L cell culture/ purification/filling capacity. The company will begin the second-stage of construction to expand its production scale.

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus